What is Trametinib?

Trametinib is an anti-cancer drug. It is a MEK inhibitor drug with anticancer activity. It inhibits MEK1 and MEK2. Trametinib has a good effect on metastatic melanoma with BRAF V600E mutation in a phase III clinical trial. In this mutation, the amino acid valine (V) at position 600 in the BRAF protein has been replaced by glutamic acid, making the mutant BRAF protein constitutively active.

Packing &shipping&Payment

Company information
Hebei Mojin Biotechnology Co., Ltd, Our company is a professional in 4'-Methylacetophenone,Levamisole hydrochloride ,N-Methylformamide and other chemical reagents research and development production enterprises. Our business covers more than 30 countries, most of the big customers come from Europe, America and other countries in the world, we can guarantee the quality and price. In recent decades, with the efforts of all employees, we have established many cooperative companies in shandong, henan, guangdong and other places. Our corporate purpose is based on the market, enhance the strength, take the road of scientific and environmental sustainable development, relying on the country. Technology r & d center, increase the investment in r & d, based on the domestic market, expand the international market, manufacturing quality products, sincere service to the society, into a modern, ecological, scientific and technological enterprise world.

Advantage
In stock